Ambulatory insulin infusion pump software, patient-dosing - ARTG 390330
Access comprehensive regulatory information for Ambulatory insulin infusion pump software, patient-dosing in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 390330 and sponsored by Ypsomed Australia Pty Ltd, manufactured by CamDiab Ltd in United Kingdom. The device registration started on June 14, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
The App is used to manage glucose levels in people with type I diabetes, aged 1 year and older, using a hybrid closed-loop approach. Additional age restrictions may apply depending on the chosen continuous glucose monitor and insulin pump.